| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 1128 |
| 1 | OFF LABEL USE | 1050 |
| 2 | INJECTION SITE PAIN | 943 |
| 3 | VIRAL LOAD INCREASED | 434 |
| 4 | PAIN | 414 |
| 5 | VIROLOGIC FAILURE | 270 |
| 6 | PYREXIA | 259 |
| 7 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 257 |
| 8 | PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT | 254 |
| 9 | PATHOGEN RESISTANCE | 251 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | PROCTITIS GONOCOCCAL | 3 | 0.3000 |
| 1 | PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT | 254 | 0.2906 |
| 2 | ANAL GONOCOCCAL INFECTION | 1 | 0.2500 |
| 3 | OROPHARYNGEAL GONOCOCCAL INFECTION | 6 | 0.2222 |
| 4 | BLOOD HIV RNA BELOW ASSAY LIMIT | 3 | 0.2000 |
| 5 | CONGENITAL CYTOMEGALOVIRUS INFECTION | 28 | 0.1647 |
| 6 | CD8 LYMPHOCYTE PERCENTAGE INCREASED | 1 | 0.1429 |
| 7 | HIV TEST FALSE POSITIVE | 5 | 0.1282 |
| 8 | SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED | 11 | 0.1222 |
| 9 | DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION | 26 | 0.1176 |